On February 10, 2026, seven biotech and pharmaceutical stocks were highlighted as top investment picks due to strong trading activity and investor interest.

On February 10, 2026, MarketBeat highlights seven biotech stocks—Danaher, Evommune, Vertex, Medpace, Moderna, argenx, and Abpro—alongside top pharmaceuticals like Eli Lilly, Pfizer, RAPT Therapeutics, AbbVie, and Gilead Sciences, and healthcare leaders UnitedHealth, Johnson & Johnson, and Hims & Hers as high-activity investment picks. These firms span drug development, clinical services, mRNA therapies, chronic disease treatments, and digital health, with strong recent trading volume indicating investor interest. The sector remains sensitive to clinical results, regulatory decisions, and patent timelines, reflecting the high-risk, high-reward nature of healthcare investing.